1. Home
  2. CORT vs ELP Comparison

CORT vs ELP Comparison

Compare CORT & ELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • ELP
  • Stock Information
  • Founded
  • CORT 1998
  • ELP 1954
  • Country
  • CORT United States
  • ELP Brazil
  • Employees
  • CORT N/A
  • ELP N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • ELP Electric Utilities: Central
  • Sector
  • CORT Health Care
  • ELP Utilities
  • Exchange
  • CORT Nasdaq
  • ELP Nasdaq
  • Market Cap
  • CORT 7.6B
  • ELP 6.9B
  • IPO Year
  • CORT N/A
  • ELP 1997
  • Fundamental
  • Price
  • CORT $72.87
  • ELP $9.31
  • Analyst Decision
  • CORT Strong Buy
  • ELP
  • Analyst Count
  • CORT 4
  • ELP 0
  • Target Price
  • CORT $139.00
  • ELP N/A
  • AVG Volume (30 Days)
  • CORT 658.4K
  • ELP 186.2K
  • Earning Date
  • CORT 10-29-2025
  • ELP 11-05-2025
  • Dividend Yield
  • CORT N/A
  • ELP 4.72%
  • EPS Growth
  • CORT N/A
  • ELP 30.24
  • EPS
  • CORT 1.11
  • ELP 0.19
  • Revenue
  • CORT $716,080,000.00
  • ELP $4,381,150,343.00
  • Revenue This Year
  • CORT $30.62
  • ELP N/A
  • Revenue Next Year
  • CORT $37.68
  • ELP $6.59
  • P/E Ratio
  • CORT $65.38
  • ELP $11.94
  • Revenue Growth
  • CORT 25.71
  • ELP 8.47
  • 52 Week Low
  • CORT $35.45
  • ELP $5.72
  • 52 Week High
  • CORT $117.33
  • ELP $9.39
  • Technical
  • Relative Strength Index (RSI)
  • CORT 56.90
  • ELP 60.83
  • Support Level
  • CORT $67.32
  • ELP $8.90
  • Resistance Level
  • CORT $72.52
  • ELP $9.39
  • Average True Range (ATR)
  • CORT 2.19
  • ELP 0.15
  • MACD
  • CORT 0.36
  • ELP 0.03
  • Stochastic Oscillator
  • CORT 74.30
  • ELP 86.44

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About ELP Companhia Paranaense de Energia (COPEL)

Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.

Share on Social Networks: